The cleavable GnRH-III compounds inhibited the cell proliferation of GnRH-R-expressing cancer cells in a dose-dependent manner, while the activity of the compounds was reduced on cancer cells which possessed a lower GnRH-R expression level. The gene discussed is GNRHR; the disease is cancer.